Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LPCGF vs Hypertonic Dextrose for TMJ Disc Displacement
NCT04557878Phase 2Completed
- Start
- Oct 2020
- Primary completion
- Apr 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of liquid phase concentrated growth factor in temporomandibular joint disc displacement without reduction (DDwoR). Started Oct 2020; status: completed.
02
Drugs
liquid phase concentrated growth factor
03
Conditions
temporomandibular joint disc displacement without reduction (DDwoR)
Beyond the preview
Go deeper on NCT04557878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04557878.